<b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=''1px''><tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> ....
Awaiting price reaction for this filing.
J. B. Chemicals & Pharmaceuticals has filed a disclosure with BSE under SEBI's October 19, 2023 circular on fund raising by issuance of debt securities by large entities. The company has confirmed that it does not meet the criteria to be classified as a Large Corporate. The filing is signed by Sandeep Phadnis, Vice President - Secretarial & Company Secretary, and is dated May 14, 2025. This is a routine half-yearly/annual compliance disclosure required by SEBI, not a corporate action or fund-raising event.
No material impact on shareholders or the stock price. This is a regulatory compliance filing that confirms the company is exempt from the mandatory debt-security issuance requirement applicable to large corporates.